Algeta ASA

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Algeta ASA Company Summary

COMPANY DATA

	Homepage	www.algeta.com

---

Key Developments: Algeta ASA

	Algeta ASA (OSL:ALGETA) Algeta To Present At Lazard Capital Markets Fifth Annual Healthcare Conference NOV 13, 2008 18:31 - Article Views: 280 Algeta ASA (OSL:ALGETA) Oslo, Norway, 13 November 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today announces that Dr. Thomas Ramdahl, President and Chief Executive Officer, will be presenting at the Lazard Capital Markets 5th Annual Healthcare Conference to be held at the St. Regis Hotel, 2 East 55th Street, New York City, from November 18 - 19, 2008.
	Algeta ASA (OSL:ALGETA) Algeta Reports Results For The Third Quarter 2008 NOV 5, 2008 16:57 - Article Views: 189 Algeta ASA (OSL:ALGETA) Alpharadin - Phase III ALSYMPCA study in hormone-refractory prostate cancer patients now enrolling
	Algeta ASA (OSL:ALGETA) Algeta Schedules Third Quarter 2008 Presentation And Conference Call NOV 3, 2008 21:09 - Article Views: 228 Algeta ASA (OSL:ALGETA) Oslo, Norway, 3 November 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, will announce its third quarter 2008 results on Wednesday, 5 November 2008. A presentation to investors, analysts and the press will take place in Oslo at 08:15 CET and an international conference call will take place at 14:30 CET (details below). Algeta's President and Chief Executive Officer, Dr. Thomas Ramdahl and Chief Financial Officer, Øystein soug will participate.
	Algeta ASA (OSL:ALGETA) Change Of Financial Calendar In Algeta SEP 19, 2008 17:33 - Article Views: 265 Algeta ASA (OSL:ALGETA) Oslo, Norway, 19 September 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announced today that the third quarter results will be presented on 5 November, not on November 12 as previously announced.
	Algeta ASA (OSL:ALGETA) Extraordinary General Meeting Held In Algeta SEP 16, 2008 15:57 - Article Views: 282 Algeta ASA (OSL:ALGETA) Oslo, Norway, 16 September 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announced today that the extraordinary general meeting in Algeta ASA was held on 15 September, and all items on the agenda were resolved.
	Algeta ASA (OSL:ALGETA) - Notice Of Extra Ordinary General Meeting AUG 28, 2008 18:35 - Article Views: 253 Algeta ASA (OSL:ALGETA) Please find notice of an Extra Ordinary General Meeting in Algeta ASA enclosed.
	Algeta ASA (OSL:ALGETA) Algeta Reports Positive Headline Phase II Data On Pain Palliation with Alpharadin AUG 28, 2008 15:57 - Article Views: 127 Algeta ASA (OSL:ALGETA) Results further support the clinical profile of this novel anti-cancer agent under development to improve the survival of patients with hormone refractory prostate cancer (HRPC)
	Algeta ASA (OSL:ALGETA) Algeta Reports Results For The Second Quarter And First Half Year 2008 AUG 13, 2008 17:19 - Article Views: 135 Algeta ASA (OSL:ALGETA) Major milestone reached as phase III trial with Alpharadin in advanced prostate cancer begins
	Algeta Begins First US Clinical Trial Of Alpharadin In Men With Advanced Prostate Cancer AUG 12, 2008 16:51 - Article Views: 453 Algeta ASA (OSL:ALGETA) Oslo, Norway, 12 August 2008 - Algeta ASA (OSE: ALGETA), the cancer therapeutics company, has started the first US clinical trial for its lead product Alpharadin in men with hormone-refractory prostate cancer (HRPC) that has metastasized to the skeleton.
	Algeta Schedules Second Quarter 2008 Presentation And Conference Call AUG 11, 2008 17:17 - Article Views: 269 Algeta ASA (OSL:ALGETA) Oslo, Norway, 11 August 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, will announce its second quarter 2008 results on Wednesday, 13 August 2008. A presentation to investors, analysts and the press will take place in Oslo at 08:15 CET and an international conference call will take place at 14:30 CET (details below). Algeta's President and Chief Executive Officer, Dr. Thomas Ramdahl and Chief Financial Officer, Øystein Soug will host the presentation and the call will be hosted by Thomas Ramdahl.

143 COMPANY PROFILE VIEWS

This Page Viewed: (Since Published: 143)